UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pregnancy outcomes in patients with acute kidney injury during pregnancy: a systematic review and meta-analysis

BMC pregnancy and childbirth, 2017-07, Vol.17 (1), p.235-235, Article 235

2017

Volltextzugriff (PDF)

Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials

American journal of kidney diseases, 2016-05, Vol.67 (5), p.728-741

2016

Volltextzugriff (PDF)

Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients: a meta-analysis of randomised controlled trials

BMC nephrology, 2017-06, Vol.18 (1), p.206-206, Article 206

2017

Volltextzugriff (PDF)

The soluble VEGF receptor sFlt-1 contributes to endothelial dysfunction in IgA nephropathy

PloS one, 2020-08, Vol.15 (8), p.e0234492-e0234492

2020

Volltextzugriff (PDF)

Effects and Safety of a Novel Oral Potassium-Lowering Drug-Sodium Zirconium Cyclosilicate for the Treatment of Hyperkalemia: a Systematic Review and Meta-Analysis

Cardiovascular drugs and therapy, 2021-10, Vol.35 (5), p.1057-1066

2021

Volltextzugriff (PDF)

Comprehensive analysis of aberrantly expressed profiles of mRNA and its relationship with serum galactose-deficient IgA1 level in IgA nephropathy

Journal of translational medicine, 2019-09, Vol.17 (1), p.320-320, Article 320

2019

Volltextzugriff (PDF)

Risk Factors for Pregnancy Outcomes in Patients With IgA Nephropathy: A Matched Cohort Study

American journal of kidney diseases, 2014-11, Vol.64 (5), p.730-736

2014

Volltextzugriff (PDF)

A Systematic Review and Meta-Analysis of Kidney and Pregnancy Outcomes in IgA Nephropathy

American journal of nephrology, 2016-09, Vol.44 (3), p.187-193

2016

Volltextzugriff (PDF)

Efficacy and safety of belimumab therapy for patients with lupus nephritis: A meta‐analysis and a propensity score‐matched case–control study

Immunity, Inflammation and Disease, 2023-07, Vol.11 (7), p.e954-n/a

2023

Volltextzugriff (PDF)

Elevated activating Fc gamma receptors levels correlated with susceptibility and severity of IgA nephropathy

Therapeutic advances in chronic disease, 2022-06, Vol.13, p.204062232211068-20406223221106878

2022

Volltextzugriff (PDF)

The difference between patients with nephrotic syndrome and nephrotic-range proteinuria in IgA nephropathy: a propensity score matched cohort study

BMC nephrology, 2022-04, Vol.23 (1), p.163-163, Article 163

2022

Volltextzugriff (PDF)

Pregnancy and Kidney Outcomes in Patients With IgA Nephropathy: A Cohort Study

American journal of kidney diseases, 2017-08, Vol.70 (2), p.262-269

2017

Volltextzugriff (PDF)

Prognosis of IgA Nephropathy with Stages 3b-5 CKD

Kidney & blood pressure research, 2024-01, Vol.49 (1), p.273-285

2024

Volltextzugriff (PDF)

Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy

BMC nephrology, 2022-01, Vol.23 (1), p.25-25, Article 25

2022

Volltextzugriff (PDF)

The effect of fibrinoid necrosis on the clinical features and outcomes of primary IgA nephropathy

BMC nephrology, 2023-12, Vol.24 (1), p.366-366, Article 366

2023

Volltextzugriff (PDF)

Plasma ST6GAL1 regulates IgG sialylation to control IgA nephropathy progression

Therapeutic advances in chronic disease, 2021, Vol.12, p.20406223211048644-20406223211048644

2021

Volltextzugriff (PDF)

Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy

Kidney & blood pressure research, 2019-10, Vol.44 (5), p.1196-1206

2019

Volltextzugriff (PDF)

C1GALT1 expression is associated with galactosylation of IgA1 in peripheral B lymphocyte in immunoglobulin a nephropathy

BMC nephrology, 2020-01, Vol.21 (1), p.18-18, Article 18

2020

Volltextzugriff (PDF)

Glomerular IgG deposition predicts kidney disease progression in IgA nephropathy

Heliyon, 2024-04, Vol.10 (7), p.e28509-e28509, Article e28509

2024

Volltextzugriff (PDF)

Changes E3 ubiquitin protein ligase 1 gene mRNA expression correlated with IgA1 glycosylation in patients with IgA nephropathy

Renal failure, 2019-01, Vol.41 (1), p.370-376

2019

Volltextzugriff (PDF)

ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3–5: A Network Meta-Analysis of Randomised Clinical Trials

Drugs (New York, N.Y.), 2020-06, Vol.80 (8), p.797-811

2020

Volltextzugriff (PDF)

Sodium-glucose cotransporter 2 inhibitors benefit to kidney and cardiovascular outcomes for patients with type 2 diabetes mellitus and chronic kidney disease 3b-4: A systematic review and meta-analysis of randomized clinical trials

Diabetes research and clinical practice, 2021-10, Vol.180, p.109033-109033, Article 109033

2021

Volltextzugriff (PDF)

Deciphering prognostic value of CD22 and its contribution to suppression of proinflammatory cytokines production in patients with IgA nephropathy

Immunology letters, 2023-03, Vol.255, p.40-46

2023

Volltextzugriff (PDF)

Effect and safety of LCZ696 in the treatment of hypertension: A meta-analysis of 9 RCT studies

Medicine (Baltimore), 2019-07, Vol.98 (28), p.e16093

2019

Volltextzugriff (PDF)

Decreased IgA binding levels were accompanied by increased IgG sialylation in IgA nephropathy

Clinical nephrology, 2024-08, Vol.102 (2), p.89-96

2024

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(63)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Pregnancy outcomes in patients with acute kidney injury during pregnancy: a systematic review and meta-analysis

Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials

Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients: a meta-analysis of randomised controlled trials

The soluble VEGF receptor sFlt-1 contributes to endothelial dysfunction in IgA nephropathy

Effects and Safety of a Novel Oral Potassium-Lowering Drug-Sodium Zirconium Cyclosilicate for the Treatment of Hyperkalemia: a Systematic Review and Meta-Analysis

Comprehensive analysis of aberrantly expressed profiles of mRNA and its relationship with serum galactose-deficient IgA1 level in IgA nephropathy

Risk Factors for Pregnancy Outcomes in Patients With IgA Nephropathy: A Matched Cohort Study

A Systematic Review and Meta-Analysis of Kidney and Pregnancy Outcomes in IgA Nephropathy

Efficacy and safety of belimumab therapy for patients with lupus nephritis: A meta‐analysis and a propensity score‐matched case–control study

Elevated activating Fc gamma receptors levels correlated with susceptibility and severity of IgA nephropathy

The difference between patients with nephrotic syndrome and nephrotic-range proteinuria in IgA nephropathy: a propensity score matched cohort study

Pregnancy and Kidney Outcomes in Patients With IgA Nephropathy: A Cohort Study

Prognosis of IgA Nephropathy with Stages 3b-5 CKD

Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy

The effect of fibrinoid necrosis on the clinical features and outcomes of primary IgA nephropathy

Plasma ST6GAL1 regulates IgG sialylation to control IgA nephropathy progression

Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy

C1GALT1 expression is associated with galactosylation of IgA1 in peripheral B lymphocyte in immunoglobulin a nephropathy

Glomerular IgG deposition predicts kidney disease progression in IgA nephropathy

Changes E3 ubiquitin protein ligase 1 gene mRNA expression correlated with IgA1 glycosylation in patients with IgA nephropathy

ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3–5: A Network Meta-Analysis of Randomised Clinical Trials

Sodium-glucose cotransporter 2 inhibitors benefit to kidney and cardiovascular outcomes for patients with type 2 diabetes mellitus and chronic kidney disease 3b-4: A systematic review and meta-analysis of randomized clinical trials

Deciphering prognostic value of CD22 and its contribution to suppression of proinflammatory cytokines production in patients with IgA nephropathy

Effect and safety of LCZ696 in the treatment of hypertension: A meta-analysis of 9 RCT studies

Decreased IgA binding levels were accompanied by increased IgG sialylation in IgA nephropathy

Suchergebnisse filtern